Skip to content

Author

Srujal Kacha

We have 1 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

In Silico Analysis of an Antidiabetic Drug Canagliflozin as a Potential Inhibitor of Penicillin‐Binding Protein 3 in Acinetobacter baumannii

Canagliflozin is suggested as a potent PBP3‐binding drug against the A. baumannii pathogen, which stands as a critical priority pathogen, rapidly developing resistance against the currently available antibiotic treatments, including last‐resort antibiotics.

Srujal Kacha, A. Anbarasu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.